Teva's Respiratory Drugs Contribute 11% to Specialty Medicines
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder
Teva's Unorthodox Strategy For The Respiratory Market — Will It Work
Teva pharmaceutical industries limited
Teva Announces U.S. Launch of QVAR® RediHaler™ (Beclomethasone Dipropionate HFA) Inhalation Aerosol | Business Wire
Teva's Unorthodox Strategy For The Respiratory Market — Will It Work
Teva's Key Drugs in Its Specialty Products Pipeline
Teva makes $40B offer for Mylan
Teva Pharmaceuticals Europe - From interviews with respiratory specialists to opinion pieces by doctors, Let's Talk Respiratory is a resource and knowledge hub for all things respiratory. Take a look now! http://bit.ly/2ZQiU0r
Teva Pharmaceuticals and IBM Expand Global Partnership to Enable Drug Development and Chronic Disease Management with
Teva secures FDA approval for Ajovy to prevent migraine episodes
Teva Pharmaceuticals buys smart inhaler company Gecko Health Innovations | MobiHealthNews
Teva's Unorthodox Strategy For The Respiratory Market — Will It Work
Teva closes Paragard sale to CooperSurgical - MassDevice
Teva's shares surge as first quarter results beat expectations | The Times of Israel
Teva Pharmaceuticals To Buy Gecko Health Innovations
Teva Pharmaceuticals on Twitter: "Teva was proud to join @DirectRelief and @NACHC to discuss the importance of building healthy communities by improving access to Rx medicines for the underserved at @AccessibleMeds #GRxBiosims.
Teva Pharmaceuticals
Teva Pharmaceuticals: Making Quality Health Care Accessible
Teva launches digital asthma and COPD rescue inhaler in US -
